http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0122949-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_762d928e0a4265ee6cc1c4929182d0df
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-557
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5575
filingDate 2000-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90d81e614eb29a71a5406dc69c13cd7a
publicationDate 2002-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-0122949-A3
titleOfInvention Use of alprostadil (prostaglandin e1) for producing a medicament for angioneogenesis
abstract The invention relates to the use of alprostadil for producing a medicament for angioneogenesis.
priorityDate 1999-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420007
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280723

Total number of triples: 17.